Another approach was published in a 2013 study, describing how the targeting of Dynein light chain roadblock-type 1 (DYNLRB1; also known as km23-1)in human CRC cells can suppress migration and invasion [131]. The gene discussed is DYNLRB1; the disease is colorectal carcinoma.